• In early February 2026, Oracle detailed plans to raise US$45.00–US$50.00 billion through a mix of debt and equity to expand its cloud infrastructure, while simultaneously rolling out new AI agents and manufacturing features across its Fusion Cloud and deepening healthcare and life sciences integrations on Oracle Cloud Infrastructure.
• These moves tie Oracle more tightly to AI-heavy customers such as OpenAI, TikTok, and major life sciences and healthcare providers, while materially increasing its funding needs and balance sheet commitments to support large‑scale AI and cloud workloads.
• Against this backdrop, we'll examine how D.A. Davidson's OpenAI-focused upgrade and Oracle's aggressive cloud buildout affect its AI-led investment narrative.

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Oracle Investment Narrative Recap

To own Oracle here, you need to believe its massive AI and cloud buildout will turn a US$523 billion backlog into durable, profitable revenue, while its heavy funding plan of US$45.00–US$50.00 billion does not overwhelm the balance sheet. The short term catalyst is execution on AI infrastructure for customers like OpenAI and TikTok; the biggest risk is that this demand or cash conversion disappoints. Recent AI and healthcare announcements support the AI narrative but do not materially change those core risks.

Among the latest developments, Oracle’s new AI agents embedded across Fusion Cloud Supply Chain & Manufacturing and Customer Experience are most relevant. They reinforce the thesis that Oracle is trying to make its applications “AI native,” which could deepen customer stickiness and help justify its cloud and data center expansion. If these embedded AI capabilities drive higher usage of Oracle Cloud Infrastructure, they may indirectly support the very CapEx ramp that is worrying some investors today.

Yet despite the excitement around AI, investors should not ignore how much Oracle’s future now hinges on a few large AI customers and the sheer scale of its debt funded cloud buildout...

Oracle's narrative projects $99.5 billion revenue and $25.3 billion earnings by 2028.

Uncover how Oracle's forecasts yield a $291.08 fair value, a 82% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already cautious, assuming Oracle’s revenue would grow about 15 percent a year to roughly US$90.8 billion by 2028, and the latest AI news could either ease or deepen their concern that open, interoperable cloud rivals eventually chip away at that outlook.

Explore 28 other fair value estimates on Oracle - why the stock might be worth just $165.51!

Build Your Own Oracle Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Oracle research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Oracle research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Oracle's overall financial health at a glance.

Contemplating Other Strategies?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Find 51 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.